Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$0.31 - $0.44 $4,681 - $6,644
15,100 Added 32.4%
61,700 $22,000
Q1 2024

May 07, 2024

SELL
$0.28 - $0.53 $3,640 - $6,890
-13,000 Reduced 21.81%
46,600 $20,000
Q4 2023

Feb 14, 2024

SELL
$0.26 - $0.55 $14,326 - $30,305
-55,100 Reduced 48.04%
59,600 $17,000
Q3 2023

Nov 14, 2023

BUY
$0.46 - $0.87 $34,362 - $64,989
74,700 Added 186.75%
114,700 $57,000
Q2 2023

Aug 11, 2023

BUY
$0.78 - $1.22 $11,076 - $17,324
14,200 Added 55.04%
40,000 $35,000
Q1 2023

May 16, 2023

SELL
$0.95 - $1.62 $5,130 - $8,748
-5,400 Reduced 17.31%
25,800 $29,000
Q4 2022

Feb 14, 2023

SELL
$0.92 - $40.2 $496,800 - $21.7 Million
-540,000 Reduced 94.54%
31,200 $31,000
Q3 2022

Nov 14, 2022

BUY
$0.33 - $73.0 $173,349 - $38.3 Million
525,300 Added 1144.44%
571,200 $1.6 Million
Q2 2022

Aug 15, 2022

SELL
$2.1 - $4.12 $171,780 - $337,016
-81,800 Reduced 64.06%
45,900 $116,000
Q1 2022

May 16, 2022

SELL
$2.42 - $4.42 $54,208 - $99,008
-22,400 Reduced 14.92%
127,700 $503,000
Q4 2021

Feb 14, 2022

BUY
$3.95 - $7.53 $63,595 - $121,233
16,100 Added 12.01%
150,100 $615,000
Q3 2021

Nov 15, 2021

BUY
$6.83 - $13.58 $915,220 - $1.82 Million
134,000 New
134,000 $915,000

Others Institutions Holding CLNN

About Clene Inc.


  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.